Maxmarvil Tablets
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- Category
- Pharmaceuticals
Yuyu Pharma., Inc.
- Country / Year Established
-
South Korea
/
- Business type
- Others
- Verified Certificate
-
16
| Product name | Maxmarvil Tablets | Certification | - |
|---|---|---|---|
| Category | Pharmaceuticals | Ingredients | - |
| Keyword | - | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | Stock | - | |
| Supply type | - | HS code | - |
Product Information
Features
- Maxmarvil tablet is the world’s first new combination drug containing alendronate.
- Yuyu has developed it for 7 years (1998 ~ 2004) in cooperation with academic centers having invested economic cost 740,000 USD.
- Maxmarvil tablet is a fixed combination product of osteoclast inhibitor alendronate and osteoblast activator calcitriol (activated Vitamin D) with an optimum weight ratio (10,000:1). Therefore, it is not necessary to intake additional calcium or vitamin D separately as well as brings the synergic effect in osteoporosis treatment.
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Seung Pil, Yu
- Address
- Yuyu Bldg., 197, Dongho-ro, Jung-gu, Seoul, Korea
- Product Category
- Herbal Medicine,Pharmaceuticals
- No. of Total Employees
- 101-500
- Company introduction
-
Yuyu Pharma., Inc. is one of the leading innovators and marketers of pharmaceutical products with over 250 employees nationwide in Korea.
Yuyu's mission is to improve the quality life by providing the most effective and safe medical treatments in the market.The company has kept this promise since its establishment in 1941 and will continue to do so with the introduction of new generation of medicines.
Recently, Yuyu has begun to focus more on how to serve the aging population, as people are living longer and searching for ways to live a ealthier life. This has led us to be a specialist in the fields of degenerative neurological disease, osteoporosis and cerebrovascular diseases. Yuyu's treatment in these three areas has proven to be fruitful and we will continue to focus in these therapeutic categories.In order to increase out area of expertise, we also have plans to further expand out presence in the field of gastrointestinal diseasea and antibiotics.
- Main Product
_2.jpg "Korea Red Ginseng extract_Plus__1")
